Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

被引:129
作者
Ghosh, A [1 ]
Zhang, WW [1 ]
Matlashewski, G [1 ]
机构
[1] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
基金
加拿大健康研究院;
关键词
vaccine; Leishmania donovani; macrophage;
D O I
10.1016/S0264-410X(01)00322-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The A2 genes of Leishmania donovani encode amastigote-specific A2 proteins, which are considered to be virulence factors required for the survival of this protozoan parasite in the mammalian host. The A2 genes are present within a multigene family and corresponding A2 proteins are composed predominantly of multiple copies of a 10 amino acid repeat sequences. A2-specific antibodies have been detected in the sera of patients suffering from visceral leishmaniasis (VL) and it has been shown that generation of A2 deficient L. donovani resulted in an avirulent phenotype. In this report, we show that immunization of mice with recombinant A2 protein conferred significant protection against challenge infection with L. donovani. The protection correlated with in vitro splenocyte proliferation, production of IFN-gamma in response to A2 protein and the presence of A2-specific antibodies in the sera of immunized mice. These data demonstrate that A2 represents a potential antigen for protection against infection with L. donovani and VL. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 59 条
[1]   CONTROLLED FIELD TRIALS OF A VACCINE AGAINST NEW-WORLD CUTANEOUS LEISHMANIASIS [J].
ANTUNES, CM ;
MAYRINK, W ;
MAGALHAES, PA ;
COSTA, CA ;
MELO, MN ;
DIAS, M ;
MICHALICK, MSM ;
WILLIAMS, P ;
LIMA, AO ;
VIEIRA, JBF ;
SCHETTINI, APM .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1986, 15 (04) :572-580
[2]  
BAHAR K, 1993, P 13 INT C TROP MED
[3]   VISCERAL LEISHMANIASIS - MORE PREVALENT AND MORE PROBLEMATIC [J].
BAILY, GG ;
NANDY, A .
JOURNAL OF INFECTION, 1994, 29 (03) :241-247
[4]   Interaction of Leishmania gp63 with cellular receptors for fibronectin [J].
Brittingham, A ;
Chen, G ;
McGwire, BS ;
Chang, KP ;
Mosser, DM .
INFECTION AND IMMUNITY, 1999, 67 (09) :4477-4484
[5]   IMMUNOLOGICAL MARKERS OF CLINICAL EVOLUTION IN CHILDREN RECENTLY INFECTED WITH LEISHMANIA-DONOVANI-CHAGASI [J].
CARVALHO, EM ;
BARRAL, A ;
PEDRALSAMPAIO, D ;
BARRALNETTO, M ;
BADARO, R ;
ROCHA, H ;
JOHNSON, WD .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :535-540
[6]  
CARVALHO EM, 1994, J IMMUNOL, V152, P5949
[7]   IMMUNE-RESPONSE IN HEALTHY-VOLUNTEERS VACCINATED WITH KILLED LEISHMANIAL PROMASTIGOTES PLUS BCG .1. SKIN-TEST REACTIVITY, T-CELL PROLIFERATION AND INTERFERON-GAMMA PRODUCTION [J].
CASTES, M ;
BLACKWELL, J ;
TRUJILLO, D ;
FORMICA, S ;
CABRERA, M ;
ZORRILLA, G ;
RODAS, A ;
CASTELLANOS, PL ;
CONVIT, J .
VACCINE, 1994, 12 (11) :1041-1051
[8]   The developmental expression of Leishmania donovani A2 amastigote-specific genes is post-transcriptionally mediated and involves elements located in the 3'-untranslated region [J].
Charest, H ;
Zhang, WW ;
Matlashewski, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) :17081-17090
[9]   DEVELOPMENTAL GENE-EXPRESSION IN LEISHMANIA-DONOVANI - DIFFERENTIAL CLONING AND ANALYSIS OF AN AMASTIGOTE-STAGE-SPECIFIC GENE [J].
CHAREST, H ;
MATLASHEWSKI, G .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :2975-2984
[10]  
Das Gupta R K, 1995, J Commun Dis, V27, P124